L'Oreal will pay €3.4B of the total sum in cash and the rest by handing over 50% of its stake in Swiss dermatology pharmaceuticals company Galderma, a 50-50 joint venture between Nestle and the French firm. The latter deal has an enterprise value of €3.1B.
Nestle intends to use the cash from the deal to repurchase stock and it is creating a new unit called Nestle Skin Health, using Galderma as the basis.
L'Oreal plans to cancel all the shares that it is buying back. Following the transaction, the Bettencourt Meyers family's holding in the company will rise to 33.31% from 30.6%. (PR)